Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.
Seer Q1 Earnings Call Highlights
Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
Seer Files Patent Infringement Lawsuit Against Nanomics
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
The Radoff-JEC Group Responds to Seer, Inc.'s Rejection of April 24th Acquisition Proposal
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
Seer, Inc. (NASDAQ:SEER) Sees Large Decrease in Short Interest
The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
Seer Shares Jump On Takeover Proposal
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Seer (NASDAQ:SEER) Trading 1.1% Higher – Here’s Why
Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
Seer, Inc. (SEER) Q3 2025 Earnings Call Transcript
Seer Reports Third Quarter 2025 Financial Results
Seer to Participate in Upcoming November Investor Conferences
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
Seer, Inc. (SEER) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Seer Appoints Isaac Ro to its Board of Directors
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Seer, Inc. (SEER) Q2 2025 Earnings Call Transcript
Seer (SEER) Q2 Revenue Jumps 32%
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
Squarepoint Ops LLC Trims Stake in Seer, Inc. (NASDAQ:SEER)
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?
Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
Seer, Inc. (SEER) Q1 2025 Earnings Call Transcript
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook